ADENOSINE
Cardiovascular Complications
Duke UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Cardiovascular Complications cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
17-beta-estradiol Peking Union Medical College Hospital | Phase 4 | BB |
Zoladex University College, London | Phase 3 | B |
TRASTUZUMAB Vanderbilt University | D | |
Inno-206 University of Sao Paulo General Hospital | D |
Same molecule, other indications
ADENOSINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →